Although some of these drugs only demonstrated an effect on NLRP3 inflammasome or caspase family and not indicated whether other pyroptosis markers such as GSDMD were also affected in the processes, the use of CPM to treat DN by inhibiting pyroptosis still has a lot of research value. This evidence concerns the gene NLRP3 and liver dysplastic nodule.